TY  - JOUR

T1  - Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

JO  - Journal of Thoracic Oncology

UR  - http://eprints.whiterose.ac.uk/101657/

PY  - 2016/09/01

AU  - Arriola E

AU  - Wheater M

AU  - Galea I

AU  - Cross N

AU  - Maishman T

AU  - Hamid D

AU  - Stanton L

AU  - Cave J

AU  - Geldart T

AU  - Mulatero C

AU  - Potter V et al

ED  - 

DO  - DOI: 10.1016/j.jtho.2016.05.028

PB  - Elsevier

VL  - 11

IS  - 9

SP  - 1511

EP  - 1521

Y2  - 2024/09/19

ER  -